Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2023-07-17
2023-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hearing Aid Quality and Reliability Study
NCT04995666
Quality Control of CE-Certified Phonak Hearing Aids - Sonova2018_05
NCT03751891
Evaluation of Hearing Aid Benefit
NCT05198713
Hearing Aid Performance Study for Different Spatial Configurations
NCT05284903
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
NCT03718975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New BTE hearing aid first, then legacy BTE hearing aid
All participants who complete speech intelligibility testing and subjective listening effort ratings with both devices, first with the new hearing aid, and then with the legacy hearing aid.
Phonak Naida BTE hearing aid
Newest generation of ultra-power Phonak BTE hearing aids
Phonak Naida legacy BTE hearing aid
Previous model/generation of the Naida BTE hearing aid
Legacy BTE hearing aid first, then new BTE hearing aid
All participants who complete speech intelligibility testing and subjective listening effort ratings with both devices, first with the new hearing aid, and then with the legacy hearing aid.
Phonak Naida BTE hearing aid
Newest generation of ultra-power Phonak BTE hearing aids
Phonak Naida legacy BTE hearing aid
Previous model/generation of the Naida BTE hearing aid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phonak Naida BTE hearing aid
Newest generation of ultra-power Phonak BTE hearing aids
Phonak Naida legacy BTE hearing aid
Previous model/generation of the Naida BTE hearing aid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+ years old
* Good written and spoken English language skills
* Able to fill in a questionnaire conscientiously
* Experienced hearing aid user
* Able to produce a reliable hearing test result
* Able to describe listening impressions/experiences and the use of the hearing aids
Exclusion Criteria
* Has auricle deformities that prevents secure placement of the hearing aids
* Has limited mobility and is not able to attend the appointments
* Not willing to wear the hearing aids for at least 8 hours per day
* Known hypersensitivity or allergy with synthetic materials
* Self reports symptoms of vertigo, dizziness, fluctuating hearing loss
* Hints of psychological problems
* Suffers from acute tinnitus in either one or both ears (occurrence less than 3 months)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sonova AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Phonak Audiology Research Center
Aurora, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRF-12872
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.